PATENT CLAIM ANALYSIS

Application Number: 16075904
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "365000"]

Abstract:
The present application discloses a pharmaceutical preparation comprising a de-epoxidized epothilone derivative, and especially relates to a preparation formulation of a compound with reduced allergens and toxicity; and also relates to the use thereof in the treatment of tumours, especially the use thereof in the treatment of solid tumours that are resistant to and fail to respond to other conventional chemotherapeutic agents, as well as the use thereof in the treatment of cancers alone or in combination with other tumour drugs or auxiliary drugs.

Claim (Index 9):
The method according to  claim 8 , wherein the compound is administered to the patient at about 10 mg/m 2 /day to 50 mg/m 2 /day.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.7451
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12763991', '13077766', '09863035', '13125303', '12855889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7104568098255488
- 35 USC 102 Novelty (BERT): 0.5168495649555717
- Combined Prediction Score: 0.6910960853385512
- Mean Citation Score: 248.371896
- Max Citation Score: 256.2341
- Similarity Product: 151.89389990320203

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test